86 related articles for article (PubMed ID: 29774536)
1. Development of a bsd-blasticidin selection system in Plasmodium berghei.
Soga A; Ko-Ketsu M; Fukumoto S
FEBS Lett; 2018 Jun; 592(11):1847-1855. PubMed ID: 29774536
[TBL] [Abstract][Full Text] [Related]
2. The selectable marker human dihydrofolate reductase enables sequential genetic manipulation of the Plasmodium berghei genome.
de Koning-Ward TF; Fidock DA; Thathy V; Menard R; van Spaendonk RM; Waters AP; Janse CJ
Mol Biochem Parasitol; 2000 Mar; 106(2):199-212. PubMed ID: 10699250
[TBL] [Abstract][Full Text] [Related]
3. Improvement of an in vitro drug selection method for generating transgenic Plasmodium berghei parasites.
Soga A; Shirozu T; Ko-Ketsu M; Fukumoto S
Malar J; 2019 Jun; 18(1):215. PubMed ID: 31238932
[TBL] [Abstract][Full Text] [Related]
4. High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei.
Janse CJ; Ramesar J; Waters AP
Nat Protoc; 2006; 1(1):346-56. PubMed ID: 17406255
[TBL] [Abstract][Full Text] [Related]
5. Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii.
Jongco AM; Ting LM; Thathy V; Mota MM; Kim K
Mol Biochem Parasitol; 2006 Apr; 146(2):242-50. PubMed ID: 16458371
[TBL] [Abstract][Full Text] [Related]
6. Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine.
Nuralitha S; Siregar JE; Syafruddin D; Roelands J; Verhoef J; Hoepelman AI; Marzuki S
Antimicrob Agents Chemother; 2016 Jan; 60(1):258-63. PubMed ID: 26503662
[TBL] [Abstract][Full Text] [Related]
7. Cloning of the blasticidin S deaminase gene (BSD) from Aspergillus terreus and its use as a selectable marker for Schizosaccharomyces pombe and Pyricularia oryzae.
Kimura M; Kamakura T; Tao QZ; Kaneko I; Yamaguchi I
Mol Gen Genet; 1994 Jan; 242(2):121-9. PubMed ID: 8159161
[TBL] [Abstract][Full Text] [Related]
8. A set of independent selectable markers for transfection of the human malaria parasite Plasmodium falciparum.
Mamoun CB; Gluzman IY; Goyard S; Beverley SM; Goldberg DE
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8716-20. PubMed ID: 10411941
[TBL] [Abstract][Full Text] [Related]
9. Blasticidin S deaminase gene from Aspergillus terreus (BSD): a new drug resistance gene for transfection of mammalian cells.
Kimura M; Takatsuki A; Yamaguchi I
Biochim Biophys Acta; 1994 Nov; 1219(3):653-9. PubMed ID: 7948022
[TBL] [Abstract][Full Text] [Related]
10. High efficacy in vitro selection procedure for generating transgenic parasites of Plasmodium berghei using an antibiotic toxic to rodent hosts.
Soga A; Bando H; Ko-Ketsu M; Masuda-Suganuma H; Kawazu SI; Fukumoto S
Sci Rep; 2017 Jun; 7(1):4001. PubMed ID: 28638105
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Glutathione Biosynthesis Sensitizes Plasmodium berghei to Antifolates.
Songsungthong W; Koonyosying P; Uthaipibull C; Kamchonwongpaisan S
Antimicrob Agents Chemother; 2016 May; 60(5):3057-64. PubMed ID: 26953195
[TBL] [Abstract][Full Text] [Related]
12. Expression of a Plasmodium gene introduced into subtelomeric regions of Plasmodium berghei chromosomes.
van Dijk MR; Janse CJ; Waters AP
Science; 1996 Feb; 271(5249):662-5. PubMed ID: 8571132
[TBL] [Abstract][Full Text] [Related]
13. Rapid positive selection of stable integrants following transfection of Plasmodium falciparum.
Wang P; Wang Q; Sims PF; Hyde JE
Mol Biochem Parasitol; 2002 Aug; 123(1):1-10. PubMed ID: 12165384
[TBL] [Abstract][Full Text] [Related]
14. New selectable markers and single crossover integration for the highly versatile Plasmodium knowlesi transfection system.
Wel Av; Kocken CH; Pronk TC; Franke-Fayard B; Thomas AW
Mol Biochem Parasitol; 2004 Mar; 134(1):97-104. PubMed ID: 14747147
[TBL] [Abstract][Full Text] [Related]
15. Development and application of a positive-negative selectable marker system for use in reverse genetics in Plasmodium.
Braks JA; Franke-Fayard B; Kroeze H; Janse CJ; Waters AP
Nucleic Acids Res; 2006 Mar; 34(5):e39. PubMed ID: 16537837
[TBL] [Abstract][Full Text] [Related]
16. Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase.
Niikura M; Komatsuya K; Inoue SI; Matsuda R; Asahi H; Inaoka DK; Kita K; Kobayashi F
Malar J; 2017 Jun; 16(1):247. PubMed ID: 28606087
[TBL] [Abstract][Full Text] [Related]
17. High efficiency transfection of Plasmodium berghei facilitates novel selection procedures.
Janse CJ; Franke-Fayard B; Mair GR; Ramesar J; Thiel C; Engelmann S; Matuschewski K; van Gemert GJ; Sauerwein RW; Waters AP
Mol Biochem Parasitol; 2006 Jan; 145(1):60-70. PubMed ID: 16242190
[TBL] [Abstract][Full Text] [Related]
18. Expansion of experimental genetics approaches for Plasmodium berghei with versatile transfection vectors.
Kooij TW; Rauch MM; Matuschewski K
Mol Biochem Parasitol; 2012 Sep; 185(1):19-26. PubMed ID: 22705315
[TBL] [Abstract][Full Text] [Related]
19. Methylene blue inhibits lumefantrine-resistant Plasmodium berghei.
Mwangi VI; Mumo RM; Kiboi DM; Omar SA; Ng'ang'a ZW; Ozwara HS
J Infect Dev Ctries; 2016 Jun; 10(6):635-42. PubMed ID: 27367013
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium berghei: diet and drug dosage regimens influencing selection of drug-resistant parasites in mice.
Merkli B; Richle R
Exp Parasitol; 1983 Jun; 55(3):372-6. PubMed ID: 6343110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
